Stereotaxis Inc (AMEX: STXS) kicked off on Friday, down -3.94% from the previous trading day, before settling in for the closing price of $2.79. Over the past 52 weeks, STXS has traded in a range of $1.54-$3.59.
During the last 5-year period, the sales drop of Healthcare Sector giant was -25.52%. While this was happening, its average annual earnings per share was recorded 15.00%. With a float of $77.50 million, this company’s outstanding shares have now reached $91.08 million.
Stereotaxis Inc (STXS) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Medical Instruments & Supplies Industry. The insider ownership of Stereotaxis Inc is 16.96%, while institutional ownership is 45.71%. The most recent insider transaction that took place on Nov 14 ’25, was worth 44,800. In this transaction Director of this company bought 20,000 shares at a rate of $2.24, taking the stock ownership to the 2,786,557 shares. Before that another transaction happened on Nov 17 ’25, when Company’s Director bought 10,000 for $2.18, making the entire transaction worth $21,800. This insider now owns 97,299 shares in total.
Stereotaxis Inc (STXS) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.09 earnings per share (EPS), lower than consensus estimate (set at -0.06) by -0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.05 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 15.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 25.48% during the next five years compared to -25.52% drop over the previous five years of trading.
Stereotaxis Inc (AMEX: STXS) Trading Performance Indicators
Take a look at Stereotaxis Inc’s (STXS) current performance indicators. Last quarter, stock had a quick ratio of 0.81. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.32.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.28, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.18 in one year’s time.
